RCC |
renal cell carcinoma |
BMI |
body mass index |
OS |
overall survival |
CSS |
cancer-specific survival |
OR |
odds ratio |
HR |
hazard ratio |
CI |
confidence interval |
NSS |
nephron sparing surgery |
RN |
radical nephrectomy |
ECOG scale |
Eastern Cooperative Oncology Group scale |
AR |
androgen receptor |
RFS |
recurrence-free survival |
ERβ |
oestrogen receptor-β |
RR |
relative risk |
SNPs |
single-nucleotide polymorphisms |
CSM |
cancer-specific mortality |
VEGF |
vascular endothelial growth factor |
TKI |
tyrosine kinase inhibitor |
mTOR |
mammalian target of rapamycin |
PD-1 |
programmed cell death protein-1 |
CTLA-4 |
cytotoxic T-lymphocyte-associated protein 4 |
PFS |
progression-free survival |